Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data

Rheumatoid Arthritis

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study

Semin Arthritis Rheum.

Montastruc F, Renoux C, Hudson M, Dell'Aniello S, Simon TA, Suissa S

doi: 10.1016/j.semarthrit.

Rheumatoid Arthritis

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.

Rheumatology (Oxford).

Moots RJ, Sebba A, Rigby W, Ostor A, Porter-Brown B, Donaldson F, Dimonaco S, Rubbert-Roth A, van Vollenhoven R, Genovese MC

doi: 10.1093/rheumatology/kew370.

Rheumatoid Arthritis

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Ann Rheum Dis.

Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC

doi: 10.1136/annrheumdis-

Rheumatoid Arthritis

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Ann Rheum Dis.

Winthrop KL, Harigai M, Genovese MC, Lindsey S, Takeuchi T, Fleischmann R, Bradley JD, Byers NL, Hyslop DL, Issa M, Nishikawa A, Rooney TP, Witt S, Dickson CL, Smolen JS, Dougados M

doi: 10.1136/annrheumdis-2019-216852.

Rheumatoid Arthritis

Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry.

Rheumatology (Oxford).

Latourte A, Gottenberg JE, Luxembourger C, Pane I, Claudepierre P, Richette P, Lafforgue P, Combe B, Cantagrel A, Sibilia J, Flipo RM, Gaudin P, Vittecoq O, Schaeverbeke T, Dougados M, Sellam J, Ravaud P, Mariette X, Seror R

doi: 10.1093/rheumatology/kew476.

Psoriasis

The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data

Br J Dermatol

Lebwohl M, Deodhar A, Griffiths CEM, Menter MA, Poddubnyy D, Bao W, Jehl V, Marfo K, Primatesta P, Shete A, Trivedi V, Mease PJ

doi: 10.1111/bjd.20136

Rheumatoid Arthritis

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Ann Rheum Dis

Winthrop KL, Nash P, Yamaoka K, Mysler E, Khan N, Camp HS, Song Y, Suboticki JL, Curtis JR

doi: 10.1136/annrheumdis-2021-220822

Rheumatoid Arthritis

Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease

Clin Rheumatol.

Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL

doi: 10.1007/

Rheumatoid Arthritis

Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality register

Arthritis Res Ther.

Cagnotto G, Willim M, Nilsson JÅ, Compagno M, Jacobsson LTH, Saevarsdottir S, Turesson C

doi: 10.1186/s13075-020-2100-y.

Related content

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry.

The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease

Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality register